25 / 27
Page 54
allied
academies
August 16-17, 2018 | Paris, France
Primary Healthcare
12
th
International Conference on
International Conference and Medicare Expo on
&
Pediatrics Health Care
Joint Event
Journal of Current Pediatric Research | Volume: 22
F
ood allergies are a growing public health and safety concern.
It is estimated that more than 50 million Americans are
affected by food allergies. Currently there are no accepted
clinical treatments in practice. The only clinically recommended
management of food hypersensitivity is avoidance, leaving
those with severe allergies vulnerable to unintentional
life-threatening exposure. Oral immunotherapy is being
investigated as a potential treatment option for those with
food allergy. This integrative review examines the most recent
literature and clinical trials retrieved from CINAHL, Cochrane
Review, MedLine Ovid, and UptoDate databases on the subject.
Although a promising treatment, oral immunotherapy is not yet
ready for clinical practice. A lack of standardization in diagnosis
of food allergies, sustained unresponsiveness post treatment,
and the safety concerns of this therapy must be addressed.
Further investigation regarding the immune pathways may be
the key to the future adoption of this therapy.
e:
shadley73@gmail.comOral immunotherapy and the prevention of food allergy-induced anaphylaxis
Samantha Hadley
MCPHS University, USA
Notes:
Pediatrics & Primary HealthCare 2018, Volume 22
DOI: 10.4066/0971-9032-C1-003